The CD52+ Mo-Mp subtype expressed CD52, S100A9 and S100A8, which has been reported as a bi-directional regulator in inflammation of autoimmune diseases via T cell activation and Treg induction (21, 22). This evidence concerns the gene S100A9 and autoimmune disease.